Signaturefd LLC Has $871,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Signaturefd LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,900 shares of the company’s stock after selling 255 shares during the quarter. Signaturefd LLC’s holdings in HCA Healthcare were worth $871,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in HCA. GSA Capital Partners LLP bought a new position in HCA Healthcare during the 3rd quarter worth about $567,000. Quest Partners LLC increased its holdings in HCA Healthcare by 384.9% during the 3rd quarter. Quest Partners LLC now owns 3,171 shares of the company’s stock worth $1,289,000 after purchasing an additional 2,517 shares in the last quarter. Pathstone Holdings LLC increased its holdings in HCA Healthcare by 23.1% during the 3rd quarter. Pathstone Holdings LLC now owns 27,589 shares of the company’s stock worth $11,213,000 after purchasing an additional 5,175 shares in the last quarter. Prospera Financial Services Inc increased its holdings in HCA Healthcare by 204.2% during the 3rd quarter. Prospera Financial Services Inc now owns 2,917 shares of the company’s stock worth $1,186,000 after purchasing an additional 1,958 shares in the last quarter. Finally, Banque Cantonale Vaudoise grew its holdings in shares of HCA Healthcare by 25.6% in the 3rd quarter. Banque Cantonale Vaudoise now owns 12,187 shares of the company’s stock valued at $4,953,000 after acquiring an additional 2,481 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on HCA shares. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Finally, KeyCorp cut their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Up 1.3 %

Shares of HCA stock opened at $334.42 on Thursday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $82.34 billion, a P/E ratio of 15.22, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The stock has a 50 day simple moving average of $320.53 and a 200 day simple moving average of $343.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 earnings per share. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.